Company Search:
Advanced Search
Sponsored Links
Madrigal Pharmaceuticals Inc Company Snapshot
Madrigal Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Madrigal Pharmaceuticals Inc with three other companies in this sector in the United States: UMeWorld Ltd (2012 sales of $166,803.00 of which 100% was Therapeutic Products), Fibrocell Science Incorporation ($153,000.00 of which 100% was Autologous Cellular Therapeutic), and Sycamore Entertainment Group Inc ($175,912.00 ).

Sales Analysis. Sales fell dramatically in 2012: During the year ended December of 2012, sales at Madrigal Pharmaceuticals Inc were $147,000.00 . This is a sharp decrease of 98.1% versus 2011, when the company's sales were $7.58 million.
  Stock Performance Chart for Madrigal Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/12/2019): 101.04
(Figures in U.S. Dollars)
1 Week -0.6%   13 Weeks 3.6%  
4 Weeks -20.3%   52 Weeks -66.0%  
Madrigal Pharmaceuticals Inc Key Data:
  Ticker: MDGL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2012 Sales 147,000
(Year Ending Jan 2013).
Employees: 17
  Currency: U.S. Dollars Market Cap: 1,557,740,147
  Fiscal Yr Ends: December Shares Outstanding: 15,417,064
  Share Type: Common Closely Held Shares: 1,747,452
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.